Publicações recentes (selecionadas)
-
Gomes CC, Diniz MG, Bastos VC, Bernardes VF, Gomez RS.
J Pathol. 2020 Feb;250(2):126-133. doi: 10.1002/path.5365.
Coura BP, de Resende TAC, de Menezes VCB, Bernardes VF, de Sousa SF, Diniz MG, Gomez RS, Gomes CC.
Arch Oral Biol. 2020 May;113:104523. doi: 10.1016/j.archoralbio.2019.104523.
First insights for targeted therapies in odontogenic myxoma.
Pereira NB, Bastos VC, de Souza JC, Diniz MG, Vitório JG, Kitten GT, de Oliveira Andrade L, de Avelar GF, Castro WH, Bernardes VF, Dias AAM, Gomez RS, Gomes CC.
Clin Oral Investig. 2020 Jul;24(7):2451-2458. doi: 10.1007/s00784-019-03107-4.
Cherubism: a systematic literature review of clinical and molecular aspects.
Chrcanovic BR, Guimarães LM, Gomes CC, Gomez RS.
Int J Oral Maxillofac Surg. 2020 Jun 30:S0901-5027(20)30213-7. doi: 10.1016/j.ijom.2020.05.021.
KRAS mutations in brown tumor of the jaws in hyperparathyroidism.
Guimarães LM, Gomes IP, Pereira TDSF, de Andrade BAB, Romañach MJ, de Lacerda JCT, Pontes HAR, Brennan PA, Rahimi S, Carlos R, Mosqueda-Taylor A, Bologna-Molina R, Passador-Santos F, Gomez RS, Gomes CC.
J Oral Pathol Med. 2020 Jun 3. doi: 10.1111/jop.13048.
Coura BP, Bernardes VF, de Sousa SF, França JA, Pereira NB, Pontes HAR, Batista AC, da Cruz Perez DE, Albuquerque Junior RLC, de Souza LB, Martins MD, Diniz MG, Gomez RS, Gomes CC.
Mod Pathol. 2019 Jun;32(6):799-806. doi: 10.1038/s41379-018-0194-4.
TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw.
Gomes CC, Gayden T, Bajic A, Harraz OF, Pratt J, Nikbakht H, Bareke E, Diniz MG, Castro WH, St-Onge P, Sinnett D, Han H, Rivera B, Mikael LG, De Jay N, Kleinman CL, Valera ET, Bassenden AV, Berghuis AM, Majewski J, Nelson MT, Gomez RS, Jabado N.
Nat Commun. 2018 Nov 1;9(1):4572. doi: 10.1038/s41467-018-06690-4.